B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets

Journal of Immunology

Volumn 173, Issue 6, 2004, Pages 3631-3639

  Yadav, Deepak ^a   Judkowski, Valeria ^a   Flodstrom Tullberg, Malin ^a,b   Sterling, Lori ^a   Redmond, William L ^a   Sherman, Linda ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 2 RECEPTOR; PADGEM PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL DEATH; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS;

EID: 4644335694     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.6.3631     Document Type: Article

References (49)

1. Buhlmann, J. E., S. K. Elkin, and A. H. Sharpe. 2003. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. J. Immunol. 170:5421.
2. Yu, X., S. Fournier, J. P. Allison, A. H. Sharpe, and R. J. Hodes. 2000. The role of B7 costimulation in CD4/CD8 T cell homeostasis. J. Immunol. 164:3543.
3. Anderson, D. E., A. H. Sharpe, and D. A. Hafler. 1999. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system. Curr. Opin. Immunol. 11:677.
4. Chatenoud, L., B. Salomon, and J. A. Bluestone. 2001. Suppressor T cellsthey're back and critical for regulation of autoimmunity! Immunol. Rev. 182:149.
5. Salomon, B., and J. A. Bluestone. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19:225.
6. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
7. Perrin, P. J., T. A. Davis, D. S. Smoot, R. Abe, C. H. June, and K. P. Lee. 1997. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation. Immunology 90:534.
8. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
9. Karandikar, N. J., C. L. Vanderlugt, T. Eagar, L. Tan, J. A. Bluestone, and S. D. Miller. 1998. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:192.
10. Windhagen, A., S. Maniak, A. Gebert, I. Ferger, and F. Heidenreich. 1999. Costimulatory molecules B7-1 and B7-2 on CSF cells in multiple sclerosis and optic neuritis. J. Neuroimmunol. 96:112.
11. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:107.
12. Slavik, J. M., J. E. Hutchcroft, and B. E. Bierer. 1999. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J. Biol. Chem. 274:3116.
13. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
14. Salomon, B., L. Rhee, H. Bour-Jordan, H. Hsin, A. Montag, B. Soliven, J. Arcella, A. M. Girvin, J. Padilla, S. D. Miller, and J. A. Bluestone. 2001. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194:677.
15. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvemick, and D. B. Wilson. 2001. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908.
16. Haskins, K., M. Portas, B. Bradley, D. Wegmann, and K. Lafferty. 1988. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37:1444.
17. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089.
18. Liang, B., M. J. Kashgarian, A. H. Sharpe, and M. J. Mamula. 2000. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J. Immunol. 165:3436.
19. + T cells. J. Immunol. 165:5035.
20. Turley, S., L. Poirot, M. Hattori, C. Benoist, and D. Mathis. 2003. Physiological β cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J. Exp. Med. 198:1527.
21. Shevach, E. M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423.
22. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461.
23. Schweitzer, A. N., and A. H. Sharpe. 1998. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 161:2762.
24. Lenschow, D. J., A. I. Sperling, M. P. Cooke, G. Freeman, L. Rhee, D. C. Decker, G. Gray, L. M. Nadler, C. C. Goodnow, and J. A. Bluestone. 1994. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1990.
25. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostatis. Science 272:60.
26. Poussin, M. A., E. Tuzun, E. Goluszko, B. G. Scott, H. Yang, J. U. Franco, and P. Christadoss. 2003. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis. J. Immunol. 170:4389.
27. Koenen, H. J., and I. Joosten. 2000. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness. Blood 95:3153.
28. + T cell activation and CTL effector function. J. Immunol. 168:3786.
29. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164:240.
30. + regulatory T cells. Immunology 109:319.
31. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:188.
32. + regulatory T cells by oral antigen administration. J. Immunol. 167:4245.
33. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169:6298.
34. + regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14:771.
35. Lepault, F., M. C. Gagnerault, C. Faveeuw, H. Bazin, and C. Boitard. 1995. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur. J. Immunol. 25:1502.
36. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71.
37. Manickasingham, S. P., S. M. Anderton, C. Burkshart, and D. C. Wraith. 1998. Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J. Immunol. 161:3827.
38. Saegusa, K., N. Ishimaru, K. Yanagi, N. Haneji, M. Nishino, M. Azuma, I. Saito, and Y. Hayashi. 2000. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjogren's syndrome (SS) through upregulated Th2 response. Clin. Exp. Immunol. 119:354.
39. Girvin, A. M., M. C. Dal Canto, L. Rhee, B. Salomon, A. Sharpe, J. A. Bluestone, and S. D. Miller. 2000. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J. Immunol. 164:136.
40. Stephens, L. A., and T. W. Kay. 1995. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse. Int. Immunol. 7:1885.
41. Okkenhaug, K., L. Wu, K. M. Garza, J. La Rose, W. Khoo, B. Odermatt, T. W. Mak, P. S. Ohashi, and R. Rottapel. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2:325.
42. Bachmann, M. F., K. McKall-Faienza, R. Schmits, D. Bouchard, J. Beach, D. E. Speiser, T. W. Mak, and P. S. Ohashi. 1997. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7:549.
43. + T cells. J. Immunol. 163:1817.
44. Whitehurst, C. E., and T. D. Geppert. 1996. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 156:1020.
45. Skak, K., S. Guerder, D. E. Picarella, N. Brenden, R. A. Flavell, and B. K. Michelsen. 2003. TNF-α impairs peripheral tolerance towards β-cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells. Eur. J. Immunol. 33:1341.
46. Tikkanen, J. M., K. B. Lemstrom, and P. K. Koskinen. 2002. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type 1-dominated immune response. Am. J. Respir. Crit. Care Med. 165:724.
47. Peterson, K. E., G. C. Sharp, H. Tang, and H. Braley-Mullen. 1999. B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis. J. Immunol. 162:1859.
48. Wolf, S. A., U. Gimsa, I. Bechmann, and R. Nitsch. 2001. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue. Glia 36:414.
49. Kiefer, R., F. Dangond, M. Mueller, K. V. Toyka, D. A. Hafler, and H. P. Hartung. 2000. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J. Neurol. Neurosurg. Psychiatry 69:362.